World's First "Dr. Katalin Karikó Exhibition" at Keio Shinanomachi Campus (September 21 - October 21)

2022.09.26

An exhibition organized by the Embassy of Hungary has been held at Keio University's Shinanomachi Campus to highlight the achievements of Hungarian-American biochemist Dr. Katalin Karikó, who was awarded the 26th Keio Medical Science Prize last year. Dr. Katalin Karikó is highly regarded for her basic research leading to the development of messenger RNA vaccines, and we hope you will enjoy the exhibition introducing her life and achievements using cartoons depicting her.

<Overview>
Date: Wednesday, September 21 to Friday, October 21, 2022
*Closed Saturdays, Sundays, and public holidays
Venue: Collaboration Hub, Center for Integrated Medical Research (1F), Keio University School of Medicine, Shinanomachi Campus, Tokyo
Directions: 1-minute walk from Shinanomachi Station (JR Sobu Line)
　　　　　5-minute walk from Kokuritsu-kyogijo Station Exit A1 (Toei Oedo Line)
Open Time: Mon. to Fri. 9:00 - 16:30
Admission: Free
Organizer: Embassy of Hungary
Cooperation: Keio University School of Medicine
Click here to see the press release.

<About the Exhibition>
This exhibition aims to promote the achievements of Hungarian bioscientist Dr. Katalin Kari-kó .The Embassy of Hungary and Keio University have collaborated on this project as Dr. Karikó was a recipient of last year's Keio Medical Science Prize. The exhibition will use photographs, var-ious exhibits, and videos to introduce her life and achievements as well as the country of Hungary.

Katalin Karikó, Ph.D.
Senior Vice President RNA Protein Replacement Therapies, BioNTech SE
Adjunct Professor, Perelman School of Medicine, University of Pennsylvania
Dr Karikó was born in Hungary in 1955 and received her PhD in Biochemistry from the Univer-sity of Szeged, Hungary. In 1985, she and moved to the United States before continuing her re-search on mRNA at BioNTech SE, headquartered in Mainz, Germany, where her technology was used to develop the new coronavirus vaccine introduced by BioNTech/Pfizer. She was awarded The Keio Medical Science Prize in 2021, and the Japan Prize in 2022.